Distribution and correlates of elevated total homocyst(e)ine: The stroke prevention in young women study

Annals of Epidemiology

Volumn 9, Issue 5, 1999, Pages 307-313

  Giles, Wayne H ^a   Kittner, Steven J ^b,c   Croft, Janet B ^a   Wozniak, Marcella A ^b   Wityk, Robert J ^d   Stern, Barney J ^e   Sloan, Michael A ^b   Price, Thomas R ^b   McCarter, Robert J ^b   Macko, Richard F ^b,c   Johnson, Constance J ^d   Feeser, Barbara R ^b   Earley, Christopher J ^d   Buchholz, David W ^d   Stolley, Paul D ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Correlates; Homocysteine; Race; Women

Indexed keywords

CHOLESTEROL; HOMOCYSTEINE; MULTIVITAMIN;

ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORRELATION FUNCTION; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; STROKE; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CEREBROVASCULAR ACCIDENT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; PREMENOPAUSE; RISK FACTORS; UNITED STATES;

EID: 0033001540     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(99)00006-X     Document Type: Article

References (39)

1. Israelsson B., Brattstrom L.E., Hultberg B.C. Homocysteine and myocardial infarction. Atherosclerosis. 72:1988;227-233.
2. Genest J.J., McNamara J.R., Salem D.N., Wilson P.W.F., Schaefer E.J., Malinow M.R. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 16:1990;114-119.
3. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullman D.et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881.
4. Pancharuniti N., Lewis C.A., Sauberlich H.E., Perkins L.L., Go R.C., Alvarez Joet al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentration and risk for early-onset coronary artery disease. Am J Clin Nutr. 59:1994;940-948.
5. Wu L.L., Wu J., Hunt S.C., James B.C., Vincent G.M., Williams R.R.et al. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 40:1994;552-561.
6. von Eckardstein A., Malinow M.R., Upson B., Heinrich J., Schulte H., Schonfeld R.et al. Effect of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)ine as a cardiovascular disease risk factor in men. Aterioscler Thromb. 14:1994;460-464.
7. Brattstrom L., Israelsson B., Norving B., Bergqvist D., Thorne J., Hultberg B.et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive disease. Atherosclerosis. 81:1990;51-60.
8. Coull B.M., Malinow M.R., Beamer N., Sexton G., Nordt F., deGarmo P. Elevated plasma homocyt(e)ine concentrations as a possible independent risk factor for stroke. Stroke. 21:1990;572-576.
9. Verhoef P., Hennekens C.H., Malinow R.M., Kok F.J., Willett W.C., Stampfer M.J. A prospective study of plasma homocysteine and risk for ischemic stroke. Stroke. 25:1994;1924-1930.
10. Malinow M.R., Kang S.S., Taylor L.M., Wong P.W., Coull B., Inahara T.et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 79:1989;1180-1188.
11. Taylor L.M., DeFrang R.D., Harris E.J., Porter J.M. The association of elevated plasma homocysteine with progressive symptomatic peripheral arterial disease. J Vasc Surg. 13:1991;128-136.
12. Boushey C.J., Beresford S.A.A., Omen G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folate intakes JAMA. 274:1995;1049-1057.
13. Selhub J., Jacques P.F., Wilson P.W., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693-2698.
14. Kang S.S., Wong P.W.K., Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 36:1987;458-462.
15. Nygard O., Vollset S.E., Refsum H., Stensvold I., Tverdal A., Nordrehaug J.E.et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study JAMA. 274:1995;1526-1533.
16. Nygard O., Refsum H., Ueland P.M., Vollset S.E. Major lifestyle determinants of plasma total homocyst(e)ine distribution. The Hordaland Homocyst(e)ine Study Am J Clin Nutr. 67:1998;263-270.
17. Kittner S.J., Malinow M.R., Seipp M.J., Upson B., Hebel J.R. Stability of blood homocyst(e)ine under epidemiological field conditions. J Clin Lab Anal. 9:1995;75-76.
18. Smolin L.A., Scheider J.A. Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection. Anal Biochem. 168:1988;374-379.
19. Malinow M.R., Sexton G., Averbuch M., Grossman M., Wilson D., Upson B. Hyperhomocyst(e)imemia in daily practice. Levels in coronary artery disease Coronary Artery Dis. 1:1990;215-220.
20. Selhub J., Jacques P.F., Bostom A.G., D'Agostino R.B., Wilson P.W., Belanger A.J. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 332:1995;286-291.
21. Federation of American Societies for Experimental Biology, Life Sciences Research Office. Prepared for the Interagency Board for Nutrition Monitoring and Related Research 1995. Third Report for Nutrition Monitoring in the United States, v. 1. Washington, DC. US Government Printing Office; 1995.
22. Motulsky A.G. Nutritional ecogenetics. Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid Am J Hum Genet. 58:1996;17-20.
23. Stevenson R.E., Schwartz C.E., Du Y.Z., Adams M.J. Differences in methylenetetrahydrofolate reductase genotype frequencies between whites and blacks. Am J Hum Genet. 60:1997;229-230.
24. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G.et al. A candidate genetic risk factor for vascular disease. A common mutation in methylenetetrahydrofolate reductase Nat Genet. 10:1995;111-113.
25. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H.et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentration. Circulation. 93:1996;7-9.
26. Christensen B., Frosst P., Lussier-Cacan S., Selhub J., Goyette P., Rosenblatt D.S.et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol. 17:1997;569-573.
27. Giles W.H., Kittner S.J., Ou C.Y., Croft J.B., Brown V., Bucholtz D.W.et al. Thermolabile methylenetetrahydrofolate reductase polymorphism (C677T) and total homocyst(e)ine concentration among African American and white women. Ethnicity Dis. 8:1998;149-157.
28. Arnesen E., Refsum H., Bønaa K.H., Ueland P.M., Førde O.H., Nordrehaug J.E. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 24:1995;704-709.
29. Kang S.S., Wong P.W.K., Cook H.Y., Norusis M., Messer J.V. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery stenosis N Engl J Med. 332:1995;268-291.
30. Araki A., Sako Y., Fukushima Y., Matsumoto M., Asada T., Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 79:1989;139-146.
31. Hultberg B., Berglund M., Andersson A., Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res. 17:1993;687-689.
32. Mansoor M.A., Bergmark C., Svardal A.M., Lonning P.E., Ueland P.M. Redux status and protein binding in plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol. 15:1995;232-240.
33. Pryor W.A., Stone K. Oxidants in cigarette smoke. radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite Ann N Y Acad Sci. 686:1993;12-28.
34. Piyathilake C.J., Macaluso M., Hine R.J., Richards E.W., Krumdieck C.L. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr. 60:1994;559-566.
35. Chen A.T., Reidy J.A., Annest J.L., Welty T.K., Zhou H.G. Increased chromosome fragility as a consequence of blood folate levels, smoking status, and coffee consumption. Environ Mol Mutagen. 13:1989;19-24.
36. Dastur D.K., Quadros E.V., Wadia N.H., Desai M.M., Bharucha E.P. Effect of vegetarianism and smoking on vitamin B-12, thiocyanate, and folate levels in the blood of normal subjects. BMJ. 3:1972;230-263.
37. Linnel J.C., Smith A.D.M., Smith C.L., Wilson J., Matthews D.M. Effects of smoking on metabolism and excretion of vitamin B-12. BMJ. 2:1968;215-216.
38. CDC Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 41(14):1992;1-5.
39. CDC Knowledge and use of folic acid by women of childbearing age - United States, 1995. MMWR. 44:1995;716-718.